Oxetacaine

Oxetacaine

280px
Systematic (IUPAC) name
2,2'-(2-hydroxyethylimino)bis [N-(1,1-dimethyl-2- phenylethyl)-N-methylacetamide]
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral, topical
Pharmacokinetic data
Biological half-life	1 hour
Identifiers
CAS Number	126-27-2 N
ATC code	C05AD06 (WHO)
PubChem	CID: 4621
ChemSpider	4460 Y
UNII	IP8QT76V17 Y
KEGG	D01152 Y
ChEMBL	CHEMBL127592 Y
Chemical data
Formula	C28H41N3O3
Molecular mass	467.643 g/mol
SMILES O=C(N(C(C)(C)Cc1ccccc1)C)CN(CCO)CC(=O)N(C(Cc2ccccc2)(C)C)C
InChI InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3 Y Key:FTLDJPRFCGDUFH-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Oxetacaine (INN, also known as oxethazaine) is a potent local anesthetic. It is administered orally (usually in combination with an antacid) for the relief of pain associated with peptic ulcer disease or esophagitis. It is also used topically in the management of hemorrhoid pain. Oral oxetacaine preparations are available in several countries, including India, South Africa, Japan and Brazil, but not the United States.

Unlike most local anesthetics, oxetacaine does not break down under strongly acidic conditions.

External links

• Strocain Prescribing information from Eisai Co.